You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 6, June 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Expansion of long-acting gas bubbles for intraocular use. Principles and practice

J. J. Crittenden, E. de Juan Jr and J. Tiedeman

Expansion of long-acting gas bubbles used in vitreoretinal surgery may lead to increased intraocular pressure and central retinal artery occlusion. To further understand the principles controlling the expansion of long-acting gases, we compared the expansion of perfluoropropane gas bubbles with that of sulfur hexafluoride gas bubbles in an in vitro model, as well as in rabbits. We found that perfluoropropane bubbles expand more rapidly and to a greater extent than do sulfur hexafluoride bubbles in the first 24 hours. The early rate of expansion of a long-acting gas is largely dependent on convection of the surrounding fluid and is independent of the type of long-acting gas. Early postoperative monitoring of intraocular pressure is, therefore, equally important when using any long-acting gas.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intravitreal Injection of Tissue Plasminogen Activator: Four Considerations
Hesse and Johnson
Arch Ophthalmol 2001;119:456-457.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.